central venous access device (CVAD) often seen in patients needing intermittent central venous access. Central venous catheters are available in a variety of sizes and lengths and can have single or multiple lumens that terminate at either staggered or "coterminal" locations along the catheter length (Figures 1 and 2) .
In addition to administration of fluids and medications, these devices allow painless collection of blood specimens because no further skin puncture is required. However, many of the subtleties of collecting blood from a CVAD have not been clearly defined. Because the patient is often receiving fluids or medications through the same port from which the blood sample is collected, contamination and erroneous test results could occur.
Before we began the current study, a survey was conducted at our institution regarding practices employed when using a CVAD to collect blood specimens. This survey identified a number of variations in registered nurses' techniques (Table 1) . These findings correlated with the results of Farjo's study 1 at York Hospital, which indicated that no consistent standard of practice for collecting CVAD blood specimens was in place across 7 units in the same hospital. Further review of institutional and laboratory policies, [2] [3] [4] national standards, [5] [6] [7] manufacturers'guidelines 8, 9 (Table 2) , previous research studies, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] and expert opinion 23 ( As discard volume increased, paired aPTT results became increasingly similar, but even with a 9-mL discard, the vascular access device results were not considered clinically trustworthy aPTT results from a CVAD lumen infusing crystalloid (without heparin) were as reliable as those from venipuncture Blood sampling from a multilumen catheter should be done with all intravenous infusions turned off Statistically significant difference between peripheral and CVAD specimens even with 25-mL discard States this is not always clinically significant Prothrombin time and aPTT values were significantly prolonged in samples collected from CVAD when compared with simultaneous peripherally collected samples Accurate samples cannot be collected from a heparinized CVAD With no waste or 10 mL waste, aPTT values significantly prolonged compared with phlebotomy specimens (both P < .001)
CVAD and venipuncture aPTTs differed with different discard amounts With a 20-mL discard, the difference was 10.6 s, compared with 12.7 s with a 10-mL discard The aPTT specimen was always obtained first
Recommended "accepting only a 2-s difference"
Recommended not using heparinized lumen to obtain blood samples Specimens should be obtained from the lumen farthest away from the catheter tip to follow when collecting a blood specimen from a CVAD. The specific focus of the current study is the activated partial thromboplastin time (aPTT) test result used to monitor the therapeutic effect of a continuous infusion of heparin. 24, 25 Previous research studies [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] on collecting specimens for aPTT tests (Table 3) can be grouped into 3 categories. Early research regarding this topic was done on patients with arterial catheters, followed by studies on patients with heparinized central venous catheters. Only 1 study 21 involved patients with central venous catheters used for continuous heparin infusion. Studies that compared aPTT values from venipuncture with aPTT values measured in samples collected from a peripheral saline lock were excluded from review.
A number of factors have been suggested as potentially influencing aPTT results. Hancock 12 specifically mentioned catheter size, type, dead space, time from catheter insertion to blood sampling, diagnosis, discard and preflush volumes, and dose and route of administration of concomitant anticoagulant. Additional considerations include liver disease, hormone therapy, and medications. 2 The following drugs have been identified as affecting aPTT results: diphenylhydantoin, heparin, warfarin, naloxone, radiographic agents, antihistamines, vitamin C (ascorbic acid), aspirin, and chlorpromazine as well as conjugated estrogen in males and oral contraceptives in females. 2 In addition, hemolyzed, lipemic, and icteric specimens also may affect aPTT results. 2, 26 No single source answered the practical questions of bedside nurses who are responsible for collecting aPTT specimens. Online institutional policies and procedures were the most readily available reference to bedside nurses but did not specify flush amount, waste amount, length of time infusion should be turned off, or preferred port for specimen collection (Table 2) .
Study Question
The purpose of this study was to determine if there is a clinically significant difference in aPTT values measured in venipuncture specimens versus CVAD specimens in hospitalized adult patients receiving continuous heparin infusions through a central catheter. The initial catalyst for this study was a high number of laboratory requests for repeat collection of central catheter blood specimens for aPTT testing because results suggested heparin contamination. Because heparin is a high-risk, high-alert drug, accurate processes to maintain safe drug levels are essential for patient safety. Subsequent investigation that demonstrated discrepancies between professional standards, laboratory policies, nursing policies, and relevant research led bedside nurses to ask for more specific guidelines to follow when the patient had a CVAD.
Methods
In this study, aPTT results from venipuncture specimens and CVAD specimens in hospitalized adults receiving continuous heparin infusions were compared. A convenience sample was obtained by identifying potential participants through daily review of computer-generated central catheter and continuous heparin infusion reports. Patients were screened by a member of the research team to determine eligibility for the study (at least 18 years of age, receiving a continuous infusion of heparin through a CVAD, having adequate peripheral veins for venipuncture and not having participated in a previous study). If the potential participant had a multilumen catheter, all unused lumens were saline locked per institution policy. All heparin infusion concentrations were 100 U/mL (25000 units heparin in 250 mL normal saline). Initial sample size was calculated to be 74 for an α of .05 and a power of 80% to detect a 2-second difference in aPTT with a standard deviation of 3 seconds. 27 Post hoc power based on the observed means and standard deviations for this sample (n = 66) was calculated to be 80.2%.
This study was reviewed and approved by the institutional review board at Advocate Health Care.
Sample
Ninety informed consents were obtained from patients hospitalized in critical care, progressive care, telemetry, and medical surgical units to allow for out-of-range values and other eventualities. The end result was 66 usable pairs of specimens ( Figure 3 ). Of these, 14 of the CVAD specimens were collected from the heparin infusion port rather than another lumen of the CVAD. Reasons for this included single-lumen-only catheters (n=3); nurse unable to aspirate specimen (n = 2); all other lumens in use with "uninterruptable" infusions, such as vasopressors, blood, total parenteral nutrition, or antiarrhythmic medications (n = 6); erroneously used heparin port despite an available alternative port (n=1); and unknown (n=2).
Sample Descriptors and Demographic Information
The mean age of the 66 participants was 68.4 years (SD, 13.7 years; SE, 1.68 years; median, 71 years; range, 26-94 years). In addition to alcohol and hormone use, which were identified in the literature as potentially influencing coagulation studies, Table 4 also includes data on the sex and race of the participants. Patients in the sample had a variety of CVADs:
• PICCs with 1, 2, or 3 lumens for infusion (all PICCs had coterminal exit points for infusions, as shown in Figure 1 ); • CVADs with multiple lumens and staggered exit points ( Figure 2 ); • Introducers with pigtails (large-bore, central catheters used as a pathway for inserting a hemodynamic monitoring device or pacemaker; the "pigtail" itself may also be used for fluids and medications); and • Implanted ports (eg, Port-a-Cath, Smiths Medical), both of which were single-lumen in this sample.
Procedure
After informed consent was obtained from the patients, timing of the blood draw was coordinated between the bedside nurse and the laboratory. Demographic and clinical data were collected via chart review. The study aPTT specimen was collected in conjunction with a regularly scheduled blood sampling. A member of the research team collected the CVAD specimen by using a defined procedure (Figure 4 ) at the same time that the phlebotomist collected the venipuncture specimen. This "defined procedure" was developed after review of all available evidence when the study commenced. Before starting data collection, the principal investigator held training sessions for the nurses serving as data collectors. These hands-on sessions simulated blood collection from a central catheter according to the study protocol. At the conclusion of the training, all study nurses were validated on their ability to collect an aPTT specimen from a CVAD according to the study protocol.
Laboratory guidelines 2,3 were followed regarding collection, transportation, and testing of specimens. Per laboratory standards, all specimens were placed in a "blue top" tube containing buffered sodium citrate. The venipuncture specimen was analyzed immediately, posted in the medical record, and used for treatment decisions. The aPTT result from the CVAD specimen was reported only to the research team. Per protocol and laboratory guidelines, if multiple specimens were being collected from the CVAD at the same time, the coagulation specimen was collected first to ensure that preservative from other laboratory tubes did not contaminate the aPTT specimen. 2 There was no extra charge to patients for participation in the study. 
ALL STEPS MUST BE FOLLOWED EXACTLY IN THIS ORDER
Verify that patient has signed study consent and HIPAA consent: Signed__________ (date)
1. Make sure phlebotomist present, explain procedure again to patient, wash hands, glove, check 2 patient identifiers 2. Label tubes as follows:
• Phlebotomy tube has lab label and is specimen A • CVAD specimen tube has computer patient ID label and special lab label B. 3. Inspect CVAD and choose port for blood collection by using following guidelines:
• Unused port is preferred, use more proximal if there are 2 or more staggered ports • If all ports in use, use most proximal nonheparin port • Use heparin port only if no other options (single-lumen catheter, other ports nonfunctional, uninterruptable infusion) 4. Wait for phlebotomist to collect peripheral specimen. Any additional specimens needed at same time should be collected peripherally-aPTT is first specimen collected after blood cultures. If phlebotomist unable to obtain enough blood from vein for additional laboratory tests ordered, RN will collect these from central catheter after the aPTT specimen for study is obtained.
Collect central catheter specimen:
a. Turn off infusions. b. If there is no unused port, choose port being used for fluids or medications, clamp intravenous tubing, disconnect the intravenous tubing from the cap temporarily. c. Clean cap of sampling port with alcohol swab. d. Attach saline-filled 10-mL syringe to sampling port. e. Flush catheter with 10 mL saline and do not remove flushing syringe-will be used to collect waste. f. Wait 1 minute-withdraw 10 mL blood to be wasted into syringe-discard. g. Use method that has been highlighted below to collect actual aPTT specimen:
Syringe method:
• Cleanse injection cap with alcohol swab.
• Attach empty 10-mL syringe and collect blood specimen.
• Collect 3 mL if only the aPTT specimen needed.
• If laboratory has been unable to collect all other specimens needed through peripheral vein, collect enough blood for all tests, collecting aPTT first after blood cultures.
• Transfer blood from sampling syringe to laboratory tube by using 18-gauge blunt-fill needle, making sure tube is filled to black line.
Transfer device method:
• Attach transfer device to central catheter cap.
• Insert coagulation tube into collection device and allow blood to fill tube to black line. h. Gently invert coagulation tube 3-4 times. 6. After blood collected, attach another 10-mL saline-filled syringe to CVAD sampling port and flush with 10 mL saline. 7. Reconnect and restart infusion if necessary, or clamp unused port if clamp present. 8. Send both specimens to laboratory with phlebotomist along with copy of form notifying laboratory personnel that patient is in the aPTT study. 9. Complete clinical environment and chart review forms.
Results
Paired blood samples from 66 hospitalized patients were analyzed by using an α of .05 unless stated otherwise. The dependent variable, difference in aPTT between the peripheral and the CVAD specimens, was not normally distributed, but instead was slightly positively skewed and significantly kurtotic. Because of this, we analyzed results by using both parametric and nonparametric tests but found minimal differences in the outcomes based on the type of test. We also reported both the mean and median for all variables.
Overall, the aPTT specimens collected via venipuncture and a CVAD were not significantly different from one another according to a Wilcoxon signed rank test (P=.06; Table 5 ). Using a 1-sample t test of the mean aPTT difference resulted in a P value of .07, also indicating no statistically significant difference.
The mean difference in aPTT did not differ by sex (P =.55), race (P=.29), or self-reported history of alcohol use (P = .85). However, the mean aPTT difference between those whose medical record indicated they were receiving hormone therapy (n=5) and those who were not (n=47) was significantly different (P=.003; Table 4 ). Eight clinical variables (Table 6) were evaluated for their effects on the aPTT difference, including type of central catheter, indication for heparin, presence of other infusions, collection method, additional specimens collected, how long the infusion(s) were turned off before specimen collection, time between collection of the 2 specimens, and waste or discard volume. The mean difference in aPTT between specimen sites (venipuncture vs CVAD) was not statistically significant for any of these clinical variables (Table 6 ).
In evaluating the various clinical factors that might affect aPTT results, we were interested in whether collecting the specimen from the heparin port itself made a difference, as well as whether the sampling port being proximal or distal to the infusion port had any effect (Figure 2 ). An unanticipated finding was that the majority (n = 50) of CVADs were PICCs in which all lumens exit together at the end of the catheter, which we describe as "coterminal" (Figure 1) . Thus, most of the blood specimens in this study were collected from lumens that were coterminal with the heparin infusion (n = 42). In the remaining 8 cases, the PICC had only a single lumen that was used for both heparin infusion and blood sampling. Information regarding the specific location of the heparin infusion was not available in 1 case, so that participant was excluded from this part of the analysis, leaving a sample of 65 paired specimens. The paired blood samples (venipuncture vs CVAD aPTT values) were grouped as follows:
• CVAD specimen collected from the port used to infuse heparin (n=14) • CVAD specimen collected from a port proximal to the heparin infusion port (n=4) • CVAD specimen collected from a port distal to the heparin infusion port (n=5) • CVAD specimen collected from a port not used to infuse heparin but coterminal with the heparin infusion port (n=42) The Kruskal-Wallis test of whether the distribution of the aPTT difference (venipuncture vs CVAD specimen) between sampling sites relative to the heparin infusion port was the same or not did result in a significant test value (P = .008; Table 7 ). This result indicated that the distribution of aPTT difference values was different for at least 1 of the 4 specimen/port situations (the CVAD specimen being collected from the heparin infusion port or from a proximal, distal, or coterminal port). Figure 5 displays the means and medians for these 4 situations. Although the median aPTT differences for the proximal, distal, and coterminal specimens were close to 0, indicating a minimal difference between the aPTT The aPTT specimens collected via venipuncture and a CVAD were not significantly different from one another.
values from the CVAD and peripheral specimens, the mean and median values for specimens collected from the heparin infusion port were considerably longer, suggesting prolonged aPTT values for CVAD specimens collected from a port that was also being used to infuse heparin. We followed up by performing Mann-Whitney tests for the 6 possible 2-group comparisons, using a Bonferroni-corrected α of .0083 (ie, the original α of .05 divided by the 6 possible comparisons). Only 1 comparison, between specimens collected from the heparin infusion port versus specimens collected from a coterminal port, was significantly different at the corrected α.
Discussion
This study compared the aPTT results of CVAD and venipuncture specimens in patients receiving a heparin infusion via CVAD. Overall no statistically significant difference in mean aPTTs was found between the venipuncture and CVAD specimens (-7.3 seconds, P=.07; Table 5 ). The clinical importance of a difference of 7 seconds is a judgment left to the clinician; in some instances, a 7-second difference could influence whether an adjustment in the heparin infusion rate would be necessary. No statistically significant differences were found in aPTT by type of catheter (PICC vs other CVAD), indication for heparin, additional infusions, collection method (syringe vs vacutainer), whether additional laboratory specimens were collected, length of time the heparin infusion was turned off, or waste volume (10 mL vs 6 mL). A statistically significant difference in aPTTs was found when the CVAD specimen was collected from the port being used to infuse heparin (Table 7) . One might expect that if the blood sample is collected from a nonheparin but coterminal CVAD lumen, this could influence the aPTT result. However, as indicated in Figure 5 , such was not the case for this sample. No difference was apparent when CVAD specimens were collected from any of the ports not infusing heparin, whether proximal, distal, or coterminal to the lumen being used for heparin infusion. The relatively small sample sizes for the proximal and distal groups (n=4 and n=5, respectively) may have prevented finding a true effect in those situations. This small subgroup size may also have contributed to the divergent mean for the distal group, as it was more sensitive to extreme values. In the study setting, all unused CVAD ports were saline locked, so catheter exposure to heparin from routine catheter flushing was not a factor that could have altered these test results.
A statistically significant difference in aPTT was also found for those patients (n=5) whose medical record indicated they were receiving some type of hormone therapy (tamoxifen, megestrol, conjugated estrogens, or oral birth control pills). In this study, we did not collect When aPTT specimen collected from port used to infuse heparin When aPTT specimen collected from any port NOT used to infuse heparin data regarding other hormones such as insulin, antiinflammatory steroids, or thyroid replacement. Although the difference in aPTT was fairly large (mean CVAD value, 52.8 seconds longer; median value, 34.5 seconds longer), this result was based on only 5 participants. However, because of this finding, it seems advisable to include this variable in future studies of coagulation tests and to collect more specific information on the indication for and type and timing of hormone administration. Several key aspects of the specimen collection technique warrant further comment.
Length of Time to Turn Off Infusion
Although one can argue that it is common sense to turn off the infusion and flush the catheter before obtaining a blood sample, clear guidelines were not available in the literature, resulting in inconsistent practice as indicated by the results of the survey on nursing practice relative to central catheters (see Table 1 ). Those sources that mentioned turning off the infusion gave ambiguous or inconsistent recommendations regarding how long to turn the infusion off and whether the catheter should be flushed to clear residual drug before collecting discard volumes. In some cases, such as vasopressors and sedatives, it may not be possible to turn an infusion off to collect a blood specimen.
Waste Volume
The concept of discard volume or "waste" before collection of the actual specimen was the 1 variable discussed in all the available references. Recommendations varied from a specific number of milliliters (range, 3-25 mL) to a calculation based on the size of a particular catheter's dead space. The protocol defined for this study was a clinical decision based on the studies referenced. A repeat literature search was done after data collection to look for newer studies, but none were found that specifically addressed aPTT results from specimens obtained via a central catheter. Wyant and Crickman 28 did report that a 9-mL minimum discard volume for tunneled catheters and a 6-mL minimum for nontunneled catheters is required to avoid dilution or contamination from intravenous fluids.
Desired Port for Collection of Blood Specimens
Practical guidelines to assist nursing staff with port selection were not readily available or clearly defined at the time of the study, nor were actual practices assessed on the survey on nursing practice related to central catheters. None of the previous research studies addressed from which port blood samples for coagulation studies should be collected. Manufacturers' guidelines refer to this concept, but they are not readily available to bedside nurses. The Arrow Multi-Lumen Central Venous Catheter Nursing Care Guidelines 9(p14) state that the proximal port is often designated for blood sampling. This choice is made because the rapid flow of blood within the large central vein quickly carries the infusates from the more distal lumens, that might affect laboratory tests, away from the proximal sampling port.
The guidelines include terminology such as "largest lumen," but bedside practitioners usually identify lumens by color or location (proximal, medial, or distal) rather than size. The color of the lumen (red, white, blue, brown, gray, purple) is not a reliable guide because of the lack of standardization among manufacturers. In addition, the nurse's decision regarding which port to use for collecting CVAD blood samples may be influenced by:
• the functional status of central catheter ports;
• the position of the heparin infusion port relative to the central catheter ports; and • current infusates, such as continuous fluids, continuous drug infusions (eg, heparin, vasopressors, vasodilators, sedatives, and anesthetics), total parenteral nutrition, blood products, and any intermittent intravenous infusions (eg, antibiotics, electrolyte replacements). Vigilant maintenance is required to maintain patency of all central catheter ports. Although all ports are designed to be used for infusion or specimen collection, 1 or more ports can become partially blocked or completely occluded. With an occlusion, the port cannot be used for infusions or blood collection. When a partial blockage develops, the port often will accept infusions but blood cannot be collected because of a flap clot or another 1-way obstruction. The appropriate intervention is to declot the catheter, which may take up to 4 hours. Although all ports are designed to be used for infusion or specimen collection, 1 or more ports can become partially blocked or completely occluded.
If the nurse needs to collect a specimen before declotting is completed, options are to collect a venipuncture specimen or to collect the specimen from a functioning port, which could be the heparin infusion port.
In the absence of a standard approach to identify which port to use for specific infusions, compatibility of infusates may be of greater concern to nurses than which port of the CVAD is in use for the heparin infusion. In addition, when reviewing results of laboratory tests, the site of specimen collection is usually labeled only as "central line" without referencing a specific port, contributing to the lack of consistency regarding specimen collection and making it more difficult to explain out-of-range values.
One additional clinical consideration is the fact that most of the CVADs in this study were PICCs with coterminal exit points (50 of 66 cases). Thus, the concept of "staggered" lumens referenced in the Infusion Nurses Society's standards of practice 30 often did not apply. Being clear about the configuration of the patient's catheter and lumen exit points may influence clinical decisions regarding port usage (Figures 1 and 2) .
Data collection for this study preceded the 2011 revision of the Infusion Nursing Society's standards of practice and also the development of a system-wide CVAD policy. The 2011 Infusion Nursing Society's standards 30 recommend blood samples for coagulation studies not be collected from catheters with any exposure to heparin. Standard 57 30(pS78) states caution should be exercised in interpreting coagulation values with a blood sample obtained from a heparinized CVAD. Current literature does not support blood sampling for coagulation levels via heparinized CVADs; literature is inconsistent in relation to sampling from heparinized arterial catheters.
The 2011 Policies and Procedures for Infusion Nursing
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state that if the clinician is unable to obtain a blood return, the patient should be asked to change position, cough, move arm above head, or take a deep breath and hold it. Then the nurse should try to flush the CVAD with 0.9% sodium chloride solution, and if there is still no blood return, replace the blood tube.
Regarding which lumen is preferred for blood collection, the following practice criteria were published in the Infusion Nurses Society's standards of practice (2011) 30(pS79) :
The largest lumen should be used for blood sampling with multilumen CVADs. For CVADs with staggered lumen exit sites, the sample should be drawn from the one highest in the superior vena cava; for drug levels, the sample should preferentially be drawn from the catheter lumen not being used for the drug infusion.
Subsequent to the start of this study, institutional nursing policy 32 was revised to stipulate that only peripheral specimens be used for coagulation studies, a decision that is supported by these findings. Institutional laboratory policy 25 also was revised to address central venous catheters with heparin exposure more specifically. If the catheter has exposure to heparin and it is absolutely necessary to obtain coagulation studies from the CVAD, current laboratory recommendations are to flush with 10 mL 0.9% sodium chloride solution before pausing the infusion or withdrawing the waste amount, and then pause all infusions for 5 minutes before collecting the coagulation specimen.
Phlebotomy guidelines published in 2010 also offer more guidance regarding collecting CVAD specimens, for example, turn off fluids for 2 minutes and use the most proximal lumen to collect the specimen. 33 
Limitations
This study included only patients who were receiving heparin infusions. In reality, many of these same patients may also be receiving other infusions (eg, total parenteral nutrition, vasopressors, blood products, patient-controlled analgesia, and/or sedatives) through a dedicated lumen, limiting the availability of ports for specimen collection at the time the blood sample for aPTT testing is needed. Some potential participants were reluctant to get "stuck." Data collection for this study also coincided with efforts to reduce use of central catheters within the hospital, leading to a decreased number of possible patients with both a CVAD and a heparin infusion. The sample size was small for 2 of the subgroups (those with specimens collected from a lumen either proximal or distal to the heparin infusion site). Information on hormone usage and use of alcohol before hospitalization came from the admission history and was often self-reported. Alcohol
If an aPTT specimen must be collected from a CVAD, use a port that is not infusing heparin.
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